An evidence-based appraisal of reflux disease management--the Genval Workshop Report.
作者信息
Dent J, Brun J, Fendrick A, Fennerty M, Janssens J, Kahrilas P, Lauritsen K, Reynolds J, Shaw M, Talley N
出版信息
Gut. 1999 Apr;44 Suppl 2(Suppl 2):S1-16. doi: 10.1136/gut.44.2008.s1.
Abstract
摘要
相似文献
1
An evidence-based appraisal of reflux disease management--the Genval Workshop Report.
Gut. 1999 Apr;44 Suppl 2(Suppl 2):S1-16. doi: 10.1136/gut.44.2008.s1.
2
Managing gastroesophageal reflux symptoms in the very low-birth-weight infant postdischarge.
Adv Neonatal Care. 2014 Dec;14(6):381-91; quiz E1-2. doi: 10.1097/ANC.0000000000000141.
3
[Consensus conference of the DGVS on gastroesophageal reflux].
Z Gastroenterol. 2005 Feb;43(2):163-4. doi: 10.1055/s-2005-857870.
4
[Gastroesophageal reflux].
Praxis (Bern 1994). 2002 May 1;91(18):803-9.
5
What is the best treatment for patients with severe gastroesophageal reflux disease (GERD)?
J Fam Pract. 2001 Aug;50(8):656.
6
[Simple antireflux measures for management of gastroesophageal reflux disease].
Nihon Rinsho. 2000 Sep;58(9):1877-80.
7
Gastroesophageal reflux disease in infants. Myths and misconceptions, where is the evidence?
Saudi Med J. 2012 Jun;33(6):593-600.
8
[Gastroesophageal reflux treatment: from therapeutic abstention to surgery].
Arch Pediatr. 2009 Oct;16(10):1424-8. doi: 10.1016/j.arcped.2009.06.008. Epub 2009 Jul 24.
9
Guidelines on gastroesophageal reflux disease.
J Pak Med Assoc. 2015 May;65(5):532-41.
10
Respiratory involvement in the gastroesophageal reflux disesease.
Rev Med Chir Soc Med Nat Iasi. 2011 Jul-Sep;115(3):662-71.
引用本文的文献
1
Follow-up study of vonoprazan maintenance therapy for reflux esophagitis: A 96-week evaluation in patients with PPI-refractory disease.
Biomed Rep. 2025 Jul 30;23(4):160. doi: 10.3892/br.2025.2038. eCollection 2025 Oct.
2
Accuracy of the diagnosis of gastroesophageal reflux disease by a trial of potassium-competitive acid blocker treatment.
BMC Gastroenterol. 2025 May 26;25(1):406. doi: 10.1186/s12876-025-03981-1.
3
Comparing antithyroid drugs vs. radioactive iodine in paediatric Graves' disease: literature review.
Thyroid Res. 2025 May 14;18(1):27. doi: 10.1186/s13044-025-00238-7.
4
Insight into global burden of gastroesophageal reflux disease: Understanding its reach and impact.
World J Gastrointest Pharmacol Ther. 2025 Mar 5;16(1):97918. doi: 10.4292/wjgpt.v16.i1.97918.
5
Vegetarian Diet Reduced Gastroesophageal Reflux Disease in a Nationwide Longitudinal Survey in Taiwan.
Nutrients. 2024 Oct 30;16(21):3712. doi: 10.3390/nu16213712.
6
Endoscopic Advances in the Diagnosis and Management of Gastroesophageal Reflux Disease.
Medicina (Kaunas). 2024 Jul 11;60(7):1120. doi: 10.3390/medicina60071120.
7
Investigating the epidemiological relevance of secretory otitis media and neighboring organ diseases through an Internet search.
PeerJ. 2024 Mar 5;12:e16981. doi: 10.7717/peerj.16981. eCollection 2024.
8
The Role of a Plant-Only (Vegan) Diet in Gastroesophageal Reflux Disease: Online Survey of the Italian General Population.
Nutrients. 2023 Nov 8;15(22):4725. doi: 10.3390/nu15224725.
9
Functional evaluations comparing Billroth I with a large remnant stomach and Roux en Y with a small remnant stomach following laparoscopic distal gastrectomy for gastric cancer: An investigation including laparoscopic total gastrectomy.
Surg Today. 2023 Feb;53(2):232-241. doi: 10.1007/s00595-022-02557-w. Epub 2022 Aug 1.
10
Recent insights on functional heartburn and reflux hypersensitivity.
Curr Opin Gastroenterol. 2022 Jul 1;38(4):417-422. doi: 10.1097/MOG.0000000000000846.
本文引用的文献
1
2
Third generation cephalosporins in the parenteral to oral switch.
Pharmacoeconomics. 1994;5(Suppl 2):27-33. doi: 10.2165/00019053-199400052-00006.
3
The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease.
Scand J Gastroenterol. 1998 Oct;33(10):1023-9. doi: 10.1080/003655298750026697.
4
Does endoscopy have a positive impact on quality of life in dyspepsia?
Gastrointest Endosc. 1998 Jun;47(6):449-54. doi: 10.1016/s0016-5107(98)70243-3.
5
Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group.
Eur J Gastroenterol Hepatol. 1998 Feb;10(2):119-24.
6
One-week omeprazole treatment in the diagnosis of gastro-oesophageal reflux disease.
Scand J Gastroenterol. 1998 Jan;33(1):15-20. doi: 10.1080/00365529850166149.
7
Helicobacter pylori in gastro-oesophageal reflux disease: causal agent, independent or protective factor?
Gut. 1997 Sep;41(3):277-80. doi: 10.1136/gut.41.3.277.
8
Omeprazole as a diagnostic tool in gastroesophageal reflux disease.
Am J Gastroenterol. 1997 Nov;92(11):1997-2000.
9
Treatment versus management of gastroesophageal reflux disease.
Am J Gastroenterol. 1997 Nov;92(11):1959-60.
10
Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response.
Scand J Gastroenterol. 1997 Oct;32(10):974-9. doi: 10.3109/00365529709011212.
Zotero 插件